Adial Pharmaceuticals, Inc. announced that it has entered into a definitive agreement to acquire Purnovate, LLC. In connection with the transaction, Purnovate's CEO, Robert D. Thompson, will join Adial as its Vice President, Chemistry. Dr. Thompson, Chief Executive Officer of Purnovate, is a adenosine chemist that has been working in the field for over 35 years. He is the inventor of more than 20 adenosine analog patents covering tens of thousands of novel molecules and has authored dozens of scientific publications.